Moreover, highlighting our hypothesis, thioredoxin (TXN) inhibition overcomes BTZ-resistance in MM cells [23] and TXN and thioredoxin reductase 1 (TXNRD1) overexpression was also associated with BTZ resistance in a comparative proteomic profiling [12]. Here, TXN is linked to Miyoshi myopathy.